GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,459,454 | +410.2% | 160,188 | +281.5% | 0.06% | +588.9% |
Q3 2021 | $1,070,000 | +355.3% | 41,989 | +883.3% | 0.01% | +80.0% |
Q3 2020 | $235,000 | +14.1% | 4,270 | +30.9% | 0.01% | -28.6% |
Q2 2020 | $206,000 | -1.9% | 3,263 | -25.0% | 0.01% | -56.2% |
Q1 2018 | $210,000 | – | 4,351 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
Grace Capital | 131,549 | $5,697,000 | 3.60% |
Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |